Lv51
1160 积分 2024-04-26 加入
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial
4天前
已完结
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
1个月前
已完结
Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis
2个月前
已完结
Immunological aspects of cancer chemotherapy
2个月前
已完结
Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer
3个月前
已关闭
Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer
4个月前
已关闭
Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer
4个月前
已关闭
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
4个月前
已完结
Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives
4个月前
已完结
Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer
4个月前
已完结
皖公网安备34019202002308
